CareCloud Closes Medsphere Acquisition, Expanding into the Hospital IT Market
MWN-AI** Summary
CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leading healthcare technology firm, has announced its acquisition of Medsphere Systems Corporation, a provider of enterprise inpatient and ambulatory solutions with a 23-year legacy. This strategic move is poised to enhance CareCloud’s offerings in the hospital IT market, particularly in Electronic Health Records (EHR) and Revenue Cycle Management (RCM). The acquisition, finalized on August 22, 2025, enables CareCloud to extend affordable, scalable solutions to small and mid-sized hospitals across the U.S., a sector often underserved by more expensive, larger vendors.
“By merging our advanced AI capabilities with Medsphere’s established technology, we aim to modernize operations, improve patient care, and bolster financial stability for resource-constrained hospitals,” stated Stephen Snyder, Co-CEO of CareCloud. The integration of Medsphere's comprehensive product suite—which includes the CareVue EHR, RCM Cloud platform, Wellsoft Emergency Department Information System, and ChartLogic ambulatory EHR—promises to create a next-generation platform tailored to the evolving needs of health systems.
Robert Hendricks, a member of Medsphere's Board of Directors, emphasized that the merger enhances both companies' capabilities, positioning them as a formidable provider across the healthcare landscape. With more than 600 clients nationwide, this acquisition reflects CareCloud's commitment to providing innovative solutions that prioritize patient experience while alleviating administrative burdens.
The acquisition is seen as a transformative milestone for CareCloud, highlighting both companies' mission to deliver enhanced healthcare technology solutions and emphasizing the critical role of innovation in improving healthcare delivery across various settings. Additional details regarding the transaction can be found in CareCloud’s forthcoming Form 8-K filing.
MWN-AI** Analysis
CareCloud's recent acquisition of Medsphere Systems Corporation represents a strategic move to broaden its service offerings within the healthcare IT sector, specifically targeting underserved small to mid-sized hospitals. This transaction positions CareCloud to capitalize on the growing demand for affordable, integrated solutions in electronic health records (EHR) and revenue cycle management (RCM).
Investors should consider several factors when evaluating CareCloud's future post-acquisition. First, the integration of Medsphere's long-established technologies, including CareVue and the RCM Cloud, enhances CareCloud's product portfolio, allowing it to deliver comprehensive, cost-effective solutions to a market segment often overlooked by larger competitors. The potential to modernize operations in resource-constrained facilities not only addresses existing market gaps but also opens new revenue streams, placing CareCloud in a favorable competitive position.
Furthermore, Medsphere's client base of over 600 hospitals across 50 states provides an excellent foundation for CareCloud to expand its reach. This acquisition could lead to significant cross-selling opportunities for CareCloud’s existing services, increasing customer lifetime value. The shift towards integrating AI capabilities with Medsphere’s established products may enable better operational efficiencies and improve patient outcomes, critical components in a value-based healthcare landscape.
However, investors should remain cautious of potential risks associated with this acquisition. Integration challenges, maintaining customer satisfaction amidst changes, and competition from entrenched large-scale IT vendors are factors that could impact CareCloud’s ability to realize synergies from this acquisition.
In summary, while the Medsphere acquisition is a promising step for CareCloud to strengthen its market position and drive growth in the hospital IT landscape, careful monitoring of integration success and market dynamics is recommended for investors. As this strategy unfolds, stakeholders should keep an eye on quarterly earnings reports and operational updates to gauge the efficacy of the integration efforts and market penetration.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Transformational acquisition extends CareCloud’s reach into inpatient EHR and RCM, bringing affordable solutions to small and mid-sized hospitals nationwide.
SOMERSET, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced it has acquired the business assets of Medsphere Systems Corporation (“Medsphere”), a provider of enterprise inpatient and ambulatory solutions with a 23-year legacy and more than 600 current clients across 50 states and U.S. territories.
“Medsphere and CareCloud are creating a next-generation platform—faster, smarter, and well aligned with the evolving needs of health systems,” said Robert Hendricks, a member of the Board of Directors of Medsphere. “Our 600+ clients will benefit from integrating our full-stack offering with CareCloud’s AI and R&D infrastructure, positioning the combined company as an unmatched provider across the full care continuum.”
“This is one of the most transformational transactions in our history,” said Stephen Snyder, Co-Chief Executive Officer of CareCloud. “By combining our advanced AI capabilities with Medsphere’s proven technology, we will deliver an affordable, scalable solution for resource-constrained small and middle-market hospitals across the country. These facilities are often underserved by cost-prohibitive large enterprise vendors, and we see a tremendous opportunity to help them modernize operations, improve patient care, and strengthen their financial position.”
Medsphere’s hospital IT ecosystem includes:
- CareVue – integrated inpatient EHR combining clinical, financial, and patient accounting workflows
- RCM Cloud – Azure-hosted revenue cycle management platform covering scheduling, registration, billing, claims, A/R, and reporting
- Wellsoft – KLAS-recognized Emergency Department Information System (“EDIS”) for acute and behavioral health
- HealthLine – supply chain and inventory management tools for hospital environments
- ChartLogic – ambulatory EHR and practice management suite for physician practices, with a focus on orthopedics
- Phoenix & Systeem IT Managed Services – vendor-neutral services including implementation, help desk, interface management, and infrastructure support
The transaction closed on August 22, 2025. Additional details are available in CareCloud’s Form 8-K to be filed later today.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com .
Follow CareCloud on LinkedIn , X and Facebook .
For additional information, please visit our website at carecloud.com . To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com .
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
[email protected]
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
[email protected]
FAQ**
How does the acquisition of Medsphere enhance CareCloud Inc. 1Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP's appeal to investors seeking exposure to the rapidly evolving healthcare technology sector?
What specific synergies does CareCloud expect to achieve from the integration of Medsphere's technologies with its own, particularly in relation to the revenue generated by CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP?
In light of this transformational acquisition, how does CareCloud plan to alleviate the challenges faced by small and mid-sized hospitals that could positively impact the value of CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP?
What measures will CareCloud implement to ensure the successful migration and retention of Medsphere's 600+ clients while boosting the growth potential of CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock CCLDP?
**MWN-AI FAQ is based on asking OpenAI questions about CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ: CCLDP).
NASDAQ: CCLDP
CCLDP Trading
-10.6% G/L:
$19.43 Last:
23,210 Volume:
$21.49 Open:


